MagicMed Industries Inc. is a biotechnology company founded in 2020.

The company is focused on creating a library of novel derivative molecules based on classic psychedelics such as psilocybin, N,N-dimethyltryptamine (DMT), mescaline, ibogaine, MDMA and LSD.

MagicMed’s molecular derivatives library, the Psybrary™, is intended to be an essential building block from which industry partners can develop new patented products.

Name MagicMed Industries
Symbol MGIC